Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Thomas E. Mroz, MD, Director of the Spine Surgery Fellowship at Cleveland Clinic, is a board-certified Spine Surgeon in the Departments of Orthopaedic Surgery, Neurological Surgery and the Center for Spine Health at Cleveland Clinic. He graduated from Case Western Reserve University and Case Western Reserve University School of Medicine, Cleveland, Ohio. Thereafter, he completed his residency in Orthopaedic Surgery at the George Washington University Medical Center, Washington, D.C. He then completed two spinal surgery fellowships, one at the University of California, Los Angeles, and the other in the Department of Neurosurgery at the University of Tennessee, Memphis. His focus of the second fellowship was minimally invasive spine surgery.
Dr. Mroz specializes in all aspects of spinal surgery, and has a dedicated interest in minimally invasive surgery and cervical (neck) spine surgery, including radiculopathy, myelopathy, stenosis, disc herniations, cervical disc replacement, revision cervical surgery, cervical infections, cervical tumors and cervical deformity.
He is very active in research, and has lectured nationally and internationally on minimally invasive surgery and cervical spine surgery. He has authored numerous research articles and textbook chapters, and serves as a reviewer for several peer-reviewed journals. He is a member in good standing in the North American Spine Society and the American Academy of Orthopaedic Surgeons, and is a Diplomate of the American Board of Orthopaedic Surgery. He continues to have a very active role in the education of medical students, residents and fellows.
Cervical Disc Herniation, Cervical Infections, Cervical Myelopathy and Radiculopathy, Cervical Tumors, Complex Cervical Spine Surgery including Cervical Deformity, Minimally Invasive Spine Surgery, Revision Cervical Spine Surgery
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/1/2015, Dr. Mroz has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Royalty Payments. Dr. Mroz receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.